Diana Kitala

Medical Research Agency, Poland

Diana Kitala graduated with degrees in Biotechnology and Biomedical Engineering and completed postgraduate studies in clinical research, biostatistics, laboratory diagnostics, LEAN manufacturing, and Six Sigma management. She also obtained an MBA in Healthcare. She previously worked at a tissue bank and advanced therapy medicinal product (ATMP) facility. She was also a university lecturer. Currently, Dr. Kitala works for a Medical Research Agency in Poland. In 2019, she was awarded an EWMA (European Wound Management Association) grant for her project, 'Theory of constraints (TOC) and LEAN management for wider application of amniotic mesenchymal stem cells in the group of patients with chronic wounds.” In addition, she was nominated for the Golden Order for Merits of the Silesian Voivodeship.

Diana Kitala

2books edited

3chapters authored

Latest work with IntechOpen by Diana Kitala

Although the concept of using advanced therapy products such as stem cells seems to be a key strategy in the treatment of various diseases, much information in this area remains unknown. Stem cell products are highly complex, much more complex than chemical-based drugs. More and more often there are data indicating the risk of using stem cells. These risks are determined by various factors that are related to quality, biological activity, and the use itself, and thus administration. Therefore, it is very important to constantly systematize knowledge in this area. This book was created to present both the perspective of basic research, including the manipulation and changes in the properties of cells, and the changes and novelties in therapies themselves.

Go to the book